Trials / Completed
CompletedNCT00168168
ACB A Randomized Study of 2.5ug/kg/Day vs. 5ug/kg/Day Dose of G-CSF After High Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell/Marrow Transplant Recipients FILE#17159
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Alberta Health services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate recovery time on 2.5 mg/Kg/day dose of G-CSF versus 5 mg/Kg/day dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | G-CSF/Filgrastim |
Timeline
- Start date
- 2003-07-01
- Completion
- 2007-02-01
- First posted
- 2005-09-15
- Last updated
- 2010-02-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00168168. Inclusion in this directory is not an endorsement.